These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13886916)

  • 21. Hereditary pheochromocytoma and paraganglioma.
    Mazzaglia PJ
    J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pheochromocytoma: a review.
    Tsirlin A; Oo Y; Sharma R; Kansara A; Gliwa A; Banerji MA
    Maturitas; 2014 Mar; 77(3):229-38. PubMed ID: 24472290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [MEN-2, a dominantly inherited neoplasia].
    Takai S
    Gan No Rinsho; 1987 Apr; 33(5 Suppl):605-9. PubMed ID: 2885434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation.
    Jimenez C; Habra MA; Huang SC; El-Naggar A; Shapiro SE; Evans DB; Cote G; Gagel RF
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4142-5. PubMed ID: 15292360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma.
    Castinetti F; Taieb D; Henry JF; Walz M; Guerin C; Brue T; Conte-Devolx B; Neumann HP; Sebag F
    Eur J Endocrinol; 2016 Jan; 174(1):R9-18. PubMed ID: 26297495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics of pheochromocytoma and paraganglioma: new developments.
    Pigny P; Cardot-Bauters C
    Ann Endocrinol (Paris); 2010 Mar; 71(2):76-82. PubMed ID: 20031114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hereditary pheochromocytoma and paraganglioma: screening and follow-up strategies in asymptomatic mutation carriers].
    Vermalle M; Tabarin A; Castinetti F
    Ann Endocrinol (Paris); 2018 Sep; 79 Suppl 1():S10-S21. PubMed ID: 30213301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral pheochromocytoma during the postpartum period.
    Wattanachanya L; Bunworasate U; Plengpanich W; Houngngam N; Buranasupkajorn P; Sunthornyothin S; Shotelersuk V; Snabboon T
    Arch Gynecol Obstet; 2009 Dec; 280(6):1055-8. PubMed ID: 19340440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.
    Rednam SP; Erez A; Druker H; Janeway KA; Kamihara J; Kohlmann WK; Nathanson KL; States LJ; Tomlinson GE; Villani A; Voss SD; Schiffman JD; Wasserman JD
    Clin Cancer Res; 2017 Jun; 23(12):e68-e75. PubMed ID: 28620007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pheochromocytoma and the diagnosis of malignancy: recent data and the role of the pathologist].
    Patey M
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S42-4. PubMed ID: 18984296
    [No Abstract]   [Full Text] [Related]  

  • 32. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.
    Gimenez-Roqueplo AP; Dahia PL; Robledo M
    Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flushing, pheochromocytoma, and the dermatologist.
    Heymann WR
    J Am Acad Dermatol; 2006 Dec; 55(6):1075-7. PubMed ID: 17110222
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients.
    Cascón A; Inglada-Pérez L; Comino-Méndez I; de Cubas AA; Letón R; Mora J; Marazuela M; Galofré JC; Quesada-Charneco M; Robledo M
    Endocr Relat Cancer; 2013 Jun; 20(3):L1-6. PubMed ID: 23404858
    [No Abstract]   [Full Text] [Related]  

  • 36. Familial pheochromocytoma.
    Bissada MA; Safwat AS; Seyam RM; Al Sobhi S; Hanash KA; Bissada NK
    Urol Oncol; 2008; 26(4):361-3. PubMed ID: 18367101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
    Baysal BE; Maher ER
    Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pheochromocytomas: from genetic diversity to new paradigms.
    Qin Y; Buddavarapu K; Dahia PL
    Horm Metab Res; 2009 Sep; 41(9):664-71. PubMed ID: 19391076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SDHC mutations in hereditary paraganglioma/pheochromocytoma.
    Müller U; Troidl C; Niemann S
    Fam Cancer; 2005; 4(1):9-12. PubMed ID: 15883704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma.
    Koch CA; Huang SC; Zhuang Z; Stolle C; Azumi N; Chrousos GP; Vortmeyer AO; Pacak K
    Oncogene; 2002 Jan; 21(3):479-82. PubMed ID: 11821960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.